Dr. Jasper Schönermark
Jasper represents companies in legal disputes of all kinds, both judicial and extrajudicial and advises comprehensively on issues of contract and corporate law with references to IP.
Jasper advises national and international clients comprehensively on matters of contract and corporate law and on related intellectual property issues. One focus of his work is advising and representing clients in complex judicial and extrajudicial disputes and in negotiations. He specializes in legal issues of companies in the life sciences sector.
Work highlights
- Advisory of a pharma company in a dispute with a clinical trial service provider
- Advisory on a carve-out of IP assets in the run-up to a corporate transaction
- Counsel of a healthcare start-up on corporate law and regulatory issues
- Advisory and representation of a group supervisory board in a dispute with a former supervisory board member
- Advisory and representation of a "Start-Up" investor in a corporate legal dispute
- Advisory services to a vehicle manufacturer regarding the defense against potential claims for damages due to alleged product defects
Publications
- Rechtliche Schutzinstrumente für Repurposed Drugs, Carl Heymanns Verlag 2025 (im Erscheinen)
- Das Leitentscheidungsverfahren – Ein Beitrag zur effizienten Bewältigung von Massenverfahren?, WM 2025, 505 (with Dr. Philipp Rüppell)
- Akteneinsicht der Gegenpartei bei Geheimhaltungsvorbehalt der Partei, GRUR-Prax 2020, 113 (with Dr. Johannes Druschel)
Education & Engagement
Education
- Georg-August University of Göttingen
- University of Bologna
- Max-Planck-Institute for Innovation and Competition
- Technical University of Munich (TU Munich)
- Languages: German, English, Italian